Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Insogna

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Bone|April 5, 2005
Multiple melanocortin receptors are expressed in bone cellsQing Zhong, Supriya Sridhar, Ling Ruan, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 28, 2006
Effects of glucose-dependent insulinotropic peptide on osteoclast functionQing Zhong, Takashi Itokawa, Supriya Sridhar, et al.
Bone|March 29, 2024
Mitofusin 2 plays a critical role in maintaining the functional integrity of the neuromuscular-skeletal axisMeiling Zhu, Caroline Zeiss, Mark W Hamrick, et al.
Bone|February 27, 2007
Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone massDing Xie, Qing Zhong, Ke-Hong Ding, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 18, 2020
Burosumab for the Treatment of Tumor-Induced OsteomalaciaSuzanne M Jan de Beur, Paul D Miller, Thomas J Weber, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2014
Denosumab for treatment of hypercalcemia of malignancyMimi I Hu, Ilya G Glezerman, Sophie Leboulleux, et al.
Journal of Clinical Pharmacology|June 16, 2015
Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemiaXiaoping Zhang, Erik A Imel, Mary D Ruppe, et al.
Bone|October 13, 2005
Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnoverDing Xie, Hua Cheng, Mark Hamrick, et al.
Bone Reports|March 23, 2017
Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemiaMary D Ruppe, Xiaoping Zhang, Erik A Imel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 13, 2007
Impact of glucose-dependent insulinotropic peptide on age-induced bone lossKe-Hong Ding, Xing-Ming Shi, Qing Zhong, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Bone|April 5, 2005
Multiple melanocortin receptors are expressed in bone cellsQing Zhong, Supriya Sridhar, Ling Ruan, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 28, 2006
Effects of glucose-dependent insulinotropic peptide on osteoclast functionQing Zhong, Takashi Itokawa, Supriya Sridhar, et al.
Bone|March 29, 2024
Mitofusin 2 plays a critical role in maintaining the functional integrity of the neuromuscular-skeletal axisMeiling Zhu, Caroline Zeiss, Mark W Hamrick, et al.
Bone|February 27, 2007
Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone massDing Xie, Qing Zhong, Ke-Hong Ding, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 18, 2020
Burosumab for the Treatment of Tumor-Induced OsteomalaciaSuzanne M Jan de Beur, Paul D Miller, Thomas J Weber, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2014
Denosumab for treatment of hypercalcemia of malignancyMimi I Hu, Ilya G Glezerman, Sophie Leboulleux, et al.
Journal of Clinical Pharmacology|June 16, 2015
Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemiaXiaoping Zhang, Erik A Imel, Mary D Ruppe, et al.
Bone|October 13, 2005
Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnoverDing Xie, Hua Cheng, Mark Hamrick, et al.
Bone Reports|March 23, 2017
Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemiaMary D Ruppe, Xiaoping Zhang, Erik A Imel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 13, 2007
Impact of glucose-dependent insulinotropic peptide on age-induced bone lossKe-Hong Ding, Xing-Ming Shi, Qing Zhong, et al.
Pageof 6